Management of a patient with factor X deficiency with FEIBA: a case report
09. Aug. 2023
Über diesen Artikel
Artikel-Kategorie: Case Study
Online veröffentlicht: 09. Aug. 2023
Seitenbereich: 68 - 73
DOI: https://doi.org/10.2478/jhp-2023-0012
Schlüsselwörter
© 2023 Luish Borboruah et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Figure 1:

Figure 2.

Factor assay results
TEST | PATIENT VALUE | REFERENCE |
---|---|---|
Factor VIII | 173.6% | 50-150% |
Factor X | <1% | 50-150% |
Fibrinogen | 231.5mg/dl | 150-450mg/dl |
Ristocetin co factor assay | 89% | 50-175% |
Coagulation profile results
TEST | PATIENT VALUE | REFERENCE |
---|---|---|
Prothrombin time | 52.7s | 12.5s |
aPTT | 84.9s | 27.6-42.4s |
INR | 4.80 | |
Thrombin time | 13.5s | 12.0-16.0s |